Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.
De Matteis S, Scarpi E, Granato AM, Vespasiani-Gentilucci U, La Barba G, Foschi FG, Bandini E, Ghetti M, Marisi G, Cravero P, Gramantieri L, Cucchetti A, Ercolani G, Santini D, Frassineti GL, Faloppi L, Scartozzi M, Cascinu S, Casadei-Gardini A. De Matteis S, et al. Among authors: faloppi l. Int J Mol Sci. 2019 Mar 26;20(6):1503. doi: 10.3390/ijms20061503. Int J Mol Sci. 2019. PMID: 30917505 Free PMC article.
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis.
Scartozzi M, Baroni GS, Faloppi L, Paolo MD, Pierantoni C, Candelari R, Berardi R, Antognoli S, Mincarelli C, Risaliti A, Marmorale C, Antico E, Benedetti A, Cascinu S. Scartozzi M, et al. Among authors: faloppi l. J Exp Clin Cancer Res. 2010 Dec 15;29(1):164. doi: 10.1186/1756-9966-29-164. J Exp Clin Cancer Res. 2010. PMID: 21159184 Free PMC article.
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients.
Scartozzi M, Giampieri R, Maccaroni E, Del Prete M, Faloppi L, Bianconi M, Galizia E, Loretelli C, Belvederesi L, Bittoni A, Cascinu S. Scartozzi M, et al. Among authors: faloppi l. Br J Cancer. 2012 Feb 28;106(5):799-804. doi: 10.1038/bjc.2012.17. Epub 2012 Feb 7. Br J Cancer. 2012. PMID: 22315053 Free PMC article.
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab.
Scartozzi M, Giampieri R, Maccaroni E, Mandolesi A, Biagetti S, Alfonsi S, Giustini L, Loretelli C, Faloppi L, Bittoni A, Bianconi M, Del Prete M, Bearzi I, Cascinu S. Scartozzi M, et al. Among authors: faloppi l. J Transl Med. 2012 Apr 10;10:71. doi: 10.1186/1479-5876-10-71. J Transl Med. 2012. PMID: 22490361 Free PMC article.
Angiogenetic pathway as a therapeutic target in renal cell carcinoma.
Bianconi M, Scartozzi M, Faloppi L, Bittoni A, Maccaroni E, Giampieri R, Del Prete M, Burattini L, Cascinu S. Bianconi M, et al. Among authors: faloppi l. Anal Quant Cytol Histol. 2012 Feb;34(1):15-22. Anal Quant Cytol Histol. 2012. PMID: 22590815 Review.
82 results